Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
European Journal of Medicinal Chemistry|October 1, 2016
K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectivesVivek Asati, Debarshi Kar Mahapatra, Sanjay Kumar Bharti
European Journal of Medicinal Chemistry|December 3, 2014
Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agentsVivek Asati, Debarshi Kar Mahapatra, Sanjay K Bharti
Current Topics in Medicinal Chemistry|September 16, 2017
Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets PerspectivesDebarshi Kar Mahapatra, Sanjay Kumar Bharti, Vivek Asati
Bioorganic Chemistry|July 27, 2023
Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitorsRitu, Priyanka Sharma, G D Gupta, et al.
European Journal of Medicinal Chemistry|July 20, 2015
Chalcone scaffolds as anti-infective agents: structural and molecular target perspectivesDebarshi Kar Mahapatra, Sanjay Kumar Bharti, Vivek Asati
European Journal of Medicinal Chemistry|January 26, 2016
PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectivesVivek Asati, Debarshi Kar Mahapatra, Sanjay Kumar Bharti
Expert Opinion on Therapeutic Patents|June 9, 2017
MEK inhibitors in oncology: a patent review (2015-Present)Debarshi Kar Mahapatra, Vivek Asati, Sanjay Kumar Bharti
European Journal of Medicinal Chemistry|February 2, 2015
Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological perspectivesDebarshi Kar Mahapatra, Vivek Asati, Sanjay Kumar Bharti
Mini Reviews in Medicinal Chemistry|April 8, 2024
Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLCRahul Makhija, Anushka Sharma, Rahul Dubey, et al.
European Journal of Medicinal Chemistry|May 13, 2015
1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agentsShalini Bajaj, Vivek Asati, Jagadish Singh, et al.
Pageof 7